Yes GC, crucial point for Neu is not only maximising $$ value for the asset but fast tracking to ph3’s.
Which leads me to think our discussions re our future are well advanced.
Interestingly partnering with big pharma might not be ideal or TO as Neu would not be able to drive this out come.
Yes GC, crucial point for Neu is not only maximising $$ value...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $14.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.23 | 3278 | 1 |
View Market Depth
| Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |